Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Roivant Sciences Ltd. (ROIV) Profit Margins

Over the twelve months to 2026-06-30, Roivant Sciences Ltd. (ROIV) had gross margin 81.2%, operating margin -7914.8%, net margin -3535.0%, free cash flow margin -10901.0%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ROIVRoivant Sciences Ltd.Follow ROIV — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
26.4B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 15 days
LineFY2022
Mar 22
FY2023
Mar 23
FY2024
Mar 24
FY2025
Mar 25
FY2026
Mar 26
TTM
Jun 26
Trend
Gross margin————84.4%81.2%
Operating margin-2444.8%-2875.9%13746.9%-3453.3%-6235.7%-7914.8%
Net margin-1528.9%-3200.2%13294.2%-592.0%-3629.2%-3535.0%
FCF margin-1257.4%-2715.1%-2343.6%-2905.2%-9183.5%-10901.0%

USD billions · SEC XBRL

Roivant Sciences Ltd. — questions

What is Roivant Sciences Ltd.'s gross margin?
81.2% over the twelve months to 2026-06-30.
What is Roivant Sciences Ltd.'s operating margin?
-7914.8% over the twelve months to 2026-06-30.
What is Roivant Sciences Ltd.'s net profit margin?
-3535.0% over the twelve months to 2026-06-30.

Every figure on this page comes from Roivant Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.